(720 ILCS 570/216)
Sec. 216. Ephedrine.
(a) The following drug products containing ephedrine, its salts, optical
isomers and salts of optical isomers shall be exempt from the application of
Sections 312 and 313 of this Act if they: (i) may lawfully be sold
over-the-counter
without a prescription under the Federal Food, Drug, and Cosmetic Act; (ii) are
labeled and marketed in a manner consistent with Section 341.76 of Title 21 of
the Code of
Federal Regulations; (iii) are
manufactured and distributed for legitimate medicinal use in a manner that
reduces or eliminates the likelihood of abuse; and (iv) are not marketed,
advertised, or labeled for the indications of stimulation, mental alertness,
weight loss, muscle enhancement, appetite control, or energy:
(1) Solid oral dosage forms, including soft gelatin caplets, which are formulated |
(2) Anorectal preparations containing not more than 5% ephedrine.
(b) The marketing, advertising, or labeling of any product containing
ephedrine, a salt of ephedrine, an optical isomer of ephedrine, or a salt of an
optical isomer of ephedrine, for the indications of stimulation, mental
alertness, weight loss, appetite control, or energy, is prohibited. In
determining compliance with this requirement the Department may consider the
following factors:
(1) The packaging of the drug product;
(2) The name and labeling of the product;
(3) The manner of distribution, advertising, and promotion of the product;
(4) Verbal representations made concerning the product;
(5) The duration, scope, and significance of abuse or misuse of the
particular product.
(c) A violation of this Section is a Class A misdemeanor. A second or
subsequent violation of this Section is a Class 4 felony.
(d) This Section does not apply to dietary supplements, herbs, or other
natural products, including concentrates or extracts, which:
(1) are not otherwise prohibited by law; and
(2) may contain naturally occurring ephedrine, ephedrine alkaloids, or pseudoephedrine,
|